Archive for
September, 2009

These days, almost every organization or business has become a publisher of content on the web. A recent post on Dose of Digital blog points out that healthcare organizations are no exception, publishing healthcare content about diseases, treatments, dieting and exercising. But is there an information overload? Are you publishing healthcare content for the sake of publishing?

In many cases, we include this type of information because we think we have to. Our competitors do, so in order for our site to be as “good” as theirs, we do it also.

buy prescription drugs href=”http://www.healthcareitnews.com/” target=”_blank”>Healthcare IT News – Offers healthcare IT executives coverage of new technologies, IT strategies and tactics, statutory and regulatory issues, as well as provider and vendor updates. Published in partnership with HIMSS.

We’ve scoured the web and found a great mix of healthcare blogs covering science, medicine, pharma and healthcare marketing topics:

Dose buy prescription drugs online of Digital
This healthcare and pharmaceutical e-marketing blog offers news and thoughts on how the heathcare industry can leverage the digital technologies available. The blog offers information on how patients and doctors find out about products and determine if they are right for them, as well as how digital technologies can make this all simpler for everyone involved.

Is social media in healthcare on the rise? As a technology, social media is primed to become the next big tool for improving public health and educating patients, according to data presented at the 2009 National Conference on Health Communication, Marketing & Media.

During the conference, themed “Participation Powers Prevention,” Susannah Fox of the Pew Internet & American Life Project offered these facts and figures on social media in healthcare:

79% of adults in the U.S. use the Internet, up from 46% in 2000.

56% of adults have accessed the Internet wirelessly via laptop or mobile device.

What if there were no rules in pharma marketing? That’s the question Jonathan Richman asks in a recent post on the iMedia Connection Blog. For healthcare digital marketers—like marketers in every field—innovation is often inhibited by themselves, by external forces and by their own interpretation of external forces. Richman says it’s the interpretation of external forces (regulations, guidelines, etc.) that’s the most menacing.

Most of us are aware of our own limitations. At the same time, most of us know the rules and are forced to live under them. However, many times we don’t really know the rules or understand them. Worse still is when we think we know the rules, but really don’t. When this happens, we essentially create a set of “ghost rules” that inhibit our thinking and that of our colleagues.

According to a recent report “Pharmaceutical Marketing Online: Stuck in Web 1.5″ from eMarketer, despite significant growth in pharma online ad spending, there’s a bit of a disconnect between how pharmaceutical companies view the internet (information delivery channel) and their customers (interact with one another and with brands).

Having restricted their brand sites to mere online information centers – often pages of text and a slow-to-load TV commercial – pharma marketers are missing big opportunities to engage consumers and boost confidence in their brands, eMarketer said.